# Crispr Therapeutics AG (CRSP) — Revenue

## Annual Revenue (USD)

| Year | Revenue |
| --- | --- |
| 2025 | $4M |
| 2024 | $37M |
| 2023 | $371M |
| 2022 | $1M |
| 2021 | $915M |
| 2020 | $719,000 |
| 2019 | $290M |
| 2018 | $3M |
| 2017 | $41M |
| 2016 | $5M |
| 2015 | $247,000 |

## Quarterly Revenue (USD)

| Quarter | Revenue |
| --- | --- |
| 2026-03-31 | $1M |
| 2025-09-30 | $889,000 |
| 2025-06-30 | $892,000 |
| 2025-03-31 | $865,000 |
| 2024-09-30 | $602,000 |
| 2024-06-30 | $517,000 |
| 2024-03-31 | $504,000 |
| 2023-09-30 | — |
| 2023-06-30 | $70M |
| 2023-03-31 | $100M |
| 2022-09-30 | $94,000 |
| 2022-06-30 | $158,000 |
| 2022-03-31 | $940,000 |
| 2021-09-30 | $824,000 |
| 2021-06-30 | $901M |
| 2021-03-31 | $539,000 |
| 2020-09-30 | $148,000 |
| 2020-06-30 | $44,000 |
| 2020-03-31 | $157,000 |
| 2019-09-30 | $212M |
| 2019-06-30 | $318,000 |
| 2019-03-31 | $328,000 |
| 2018-09-30 | $563,000 |
| 2018-06-30 | $1M |

Source: [MarketCapTrends](https://marketcaptrends.com/company/CRSP/revenue)